id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2017-0440-0007,EPA,EPA-HQ-OPP-2017-0440,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Plant-Incorporated Protectants; CBI Substantiation and Adverse Effects Reporting",Notice,Information Collection Request (ICR),2018-06-01T04:00:00Z,2018,6,2018-06-01T04:00:00Z,2018-07-03T03:59:59Z,2018-06-01T22:35:24Z,2018-11802,0,0,090000648331e666
EPA-HQ-OPP-2017-0440-0014,EPA,EPA-HQ-OPP-2017-0440,Attachment F (Final): Display Related to OMB Control #2070-0142 –  Listings of Related Regulations in 40 CFR 9.1,Supporting & Related Material,ICR Supporting Statement,2018-06-01T04:00:00Z,2018,6,,,2018-06-02T00:36:11Z,,0,0,0900006482cbd522
EPA-HQ-OPP-2017-0440-0012,EPA,EPA-HQ-OPP-2017-0440,"Attachment D (Final): Record of Consultations for OPP ICR: “Plant-Incorporated Protectants; CBI Substantiation and Adverse Effects Reporting,”",Supporting & Related Material,ICR Supporting Statement,2018-06-01T04:00:00Z,2018,6,,,2018-06-02T00:36:42Z,,0,0,0900006482cbd520
EPA-HQ-OPP-2017-0440-0011,EPA,EPA-HQ-OPP-2017-0440,"Attachment C (Final): Federal Food, Drug, and Cosmetic Act (FFDCA) Title 21 - Food and Drugs Section 408(a)",Supporting & Related Material,ICR Supporting Statement,2018-06-01T04:00:00Z,2018,6,,,2018-06-02T00:36:57Z,,0,0,0900006482cbd51f